Articles Tagged With: Contraception
-
Survey results show use of LARC continues to rise
About 46% of participants in the 2015 Contraceptive Technology Update Contraception Survey say they have seen “dramatically more” women choosing long-acting reversible contraceptive methods such as the intrauterine device and contraceptive implant in the last year.
-
Family planners can look into the future — What contraceptive options are in the pipeline?
What new methods can clinicians look to add to their arsenal of family planning options in the upcoming years? With the recent upsurge in interest in long-acting reversible contraceptives, it’s no surprise that several possible LARC options are moving through the research pipeline.
-
When Do Combined Oral Contraceptives Start Working After Ulipristal Acetate Emergency Contraception?
In this randomized, controlled trial of the effects of combined oral contraceptives on ovarian activity after taking ulipristal acetate, investigators found that some women needed up to 14 days to achieve ovarian quiescence. Therefore, abstinence or backup contraception should be used during that time.
-
Why Aren’t Women Using Contraception?
ABSTRACT & COMMENTARY: This cross-sectional study highlights new risk factors for nonuse of contraception among women at risk for unintended pregnancy.
-
Isotretinoin and Contraception: Should iPLEDGE Be Changed?
In this study of female dermatologic patients, knowledge of the typical effectiveness of contraceptive methods increased after viewing a simple information sheet. Given the teratogenicity of isotretinoin, expanding the use of highly effective contraceptive methods among women of child-bearing potential using this medication is essential.
-
Research eyes effect of body weight and BMI impact on emergency contraception
Results of a new statistical analysis of clinical data suggest a significant drop in the efficacy of levonorgestrel emergency contraceptive pills with increasing body weight.
-
Intrauterine device and implant are effective beyond use approved by the FDA
An initial analysis of data conducted by Washington University School of Medicine in St. Louis indicates that hormonal intrauterine devices and contraceptive implants remain highly effective one year beyond their approved duration of use.
-
Options Expand for Women: FDA Approves a New Intrauterine Device
A new option in intrauterine contraception has been approved: the LILETTA intrauterine device.
-
Data reaffirm the effectiveness of LNG, copper intrauterine devices
Findings from a recent analysis of data from a large, multi-country study of women using levonorgestrel or copper intrauterine devices (IUDs) indicate that while both forms of contraception have high levels of efficacy, the levonorgestrel device daily releasing 20 mcg was associated with a significantly lower risk of pregnancy, including ectopic pregnancy, than copper IUDs. -
Weight Gain with Contraception
In this prospective cohort study, perceived weight gain was found to be an adequate predictor of actual weight gain. Depot medroxyprogesterone acetate and the contraceptive implant were associated with more weight gain than the copper IUD.